A new fluorescent imaging probe can for the first time objectively and non-invasively measure loss of smell, clinically known as anosmia. Targeting the olfactory nerve, the new tool has potential to ...
The need to improve the detection of breast cancer in women with dense breasts has resulted in the use of additional imaging modalities to supplement screening. Supplemental molecular breast imaging ...
Genomic and tumor microenvironment dynamics of brain metastases in breast cancer. ACE-Breast-02: A pivotal phase II/III trial of ARX788, a novel anti-HER2 antibody-drug conjugate (ADC), versus ...
LOS ANGELES--(BUSINESS WIRE)--Molecular Instruments® (MI), the inventor of the HCR™ platform, today announced key enhancements to its HCR™ Gold and HCR™ Pro product lines. These upgrades include ...
NEW ORLEANS—Heather Jacene, MD, assistant chief of Nuclear Medicine and Molecular Imaging at Brigham and Women’s Hospital, clinical director of Nuclear Medicine at Dana-Farber Cancer Institute, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback